Global Microsphere Drug Market Research Report 2025

Publication ID:

PB505257276

Publication Date:

May 30, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

The global market for Microsphere Drug was valued at US$ 9452 million in the year 2024 and is projected to reach a revised size of US$ 12640 million by 2031, growing at a CAGR of 4.3% during the forecast period.
Microsphere drug refers to a drug delivery system that uses micron-scale spherical particles as drug carriers, and wraps and encapsulates drug substances inside or on the surface of drug microspheres. By controlling the release rate and directional delivery of drug microspheres, this drug delivery system can achieve sustained drug release, reduce drug dose, improve drug stability, and regulate drug distribution and efficacy in vivo.
North American market for Microsphere Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Microsphere Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Microsphere Drug in Cancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Microsphere Drug include Johnson & Johnson, Takeda, Novartis, Ipsen Biopharmaceuticals, Inc, Ferring Pharmaceuticals, AstraZeneca, Pfizer, AbbVie, Beijing Biote Pharmaceutical Co.,Ltd, Livzon Pharmaceutical Group, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Microsphere Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microsphere Drug.
The Microsphere Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Microsphere Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Microsphere Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Johnson & Johnson
Takeda
Novartis
Ipsen Biopharmaceuticals, Inc
Ferring Pharmaceuticals
AstraZeneca
Pfizer
AbbVie
Beijing Biote Pharmaceutical Co.,Ltd
Livzon Pharmaceutical Group
Luye Pharma
Grand Pharmaceutical Group Limited
Segment by Type
Leuprolide Microspheres
Risperidone Microspheres
Octreotide Microspheres
Triptorelin Microspheres
other
Segment by Application
Cancer
Mental Illness
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Microsphere Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Microsphere Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Leuprolide Microspheres
1.2.3 Risperidone Microspheres
1.2.4 Octreotide Microspheres
1.2.5 Triptorelin Microspheres
1.2.6 other
1.3 Market by Application
1.3.1 Global Microsphere Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer
1.3.3 Mental Illness
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Microsphere Drug Market Perspective (2020-2031)
2.2 Global Microsphere Drug Growth Trends by Region
2.2.1 Global Microsphere Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Microsphere Drug Historic Market Size by Region (2020-2025)
2.2.3 Microsphere Drug Forecasted Market Size by Region (2026-2031)
2.3 Microsphere Drug Market Dynamics
2.3.1 Microsphere Drug Industry Trends
2.3.2 Microsphere Drug Market Drivers
2.3.3 Microsphere Drug Market Challenges
2.3.4 Microsphere Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Microsphere Drug Players by Revenue
3.1.1 Global Top Microsphere Drug Players by Revenue (2020-2025)
3.1.2 Global Microsphere Drug Revenue Market Share by Players (2020-2025)
3.2 Global Microsphere Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Microsphere Drug Revenue
3.4 Global Microsphere Drug Market Concentration Ratio
3.4.1 Global Microsphere Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Microsphere Drug Revenue in 2024
3.5 Global Key Players of Microsphere Drug Head office and Area Served
3.6 Global Key Players of Microsphere Drug, Product and Application
3.7 Global Key Players of Microsphere Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Microsphere Drug Breakdown Data by Type
4.1 Global Microsphere Drug Historic Market Size by Type (2020-2025)
4.2 Global Microsphere Drug Forecasted Market Size by Type (2026-2031)
5 Microsphere Drug Breakdown Data by Application
5.1 Global Microsphere Drug Historic Market Size by Application (2020-2025)
5.2 Global Microsphere Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Microsphere Drug Market Size (2020-2031)
6.2 North America Microsphere Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Microsphere Drug Market Size by Country (2020-2025)
6.4 North America Microsphere Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Microsphere Drug Market Size (2020-2031)
7.2 Europe Microsphere Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Microsphere Drug Market Size by Country (2020-2025)
7.4 Europe Microsphere Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Microsphere Drug Market Size (2020-2031)
8.2 Asia-Pacific Microsphere Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Microsphere Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Microsphere Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Microsphere Drug Market Size (2020-2031)
9.2 Latin America Microsphere Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Microsphere Drug Market Size by Country (2020-2025)
9.4 Latin America Microsphere Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Microsphere Drug Market Size (2020-2031)
10.2 Middle East & Africa Microsphere Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Microsphere Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Microsphere Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Microsphere Drug Introduction
11.1.4 Johnson & Johnson Revenue in Microsphere Drug Business (2020-2025)
11.1.5 Johnson & Johnson Recent Development
11.2 Takeda
11.2.1 Takeda Company Details
11.2.2 Takeda Business Overview
11.2.3 Takeda Microsphere Drug Introduction
11.2.4 Takeda Revenue in Microsphere Drug Business (2020-2025)
11.2.5 Takeda Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Microsphere Drug Introduction
11.3.4 Novartis Revenue in Microsphere Drug Business (2020-2025)
11.3.5 Novartis Recent Development
11.4 Ipsen Biopharmaceuticals, Inc
11.4.1 Ipsen Biopharmaceuticals, Inc Company Details
11.4.2 Ipsen Biopharmaceuticals, Inc Business Overview
11.4.3 Ipsen Biopharmaceuticals, Inc Microsphere Drug Introduction
11.4.4 Ipsen Biopharmaceuticals, Inc Revenue in Microsphere Drug Business (2020-2025)
11.4.5 Ipsen Biopharmaceuticals, Inc Recent Development
11.5 Ferring Pharmaceuticals
11.5.1 Ferring Pharmaceuticals Company Details
11.5.2 Ferring Pharmaceuticals Business Overview
11.5.3 Ferring Pharmaceuticals Microsphere Drug Introduction
11.5.4 Ferring Pharmaceuticals Revenue in Microsphere Drug Business (2020-2025)
11.5.5 Ferring Pharmaceuticals Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Microsphere Drug Introduction
11.6.4 AstraZeneca Revenue in Microsphere Drug Business (2020-2025)
11.6.5 AstraZeneca Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Microsphere Drug Introduction
11.7.4 Pfizer Revenue in Microsphere Drug Business (2020-2025)
11.7.5 Pfizer Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Microsphere Drug Introduction
11.8.4 AbbVie Revenue in Microsphere Drug Business (2020-2025)
11.8.5 AbbVie Recent Development
11.9 Beijing Biote Pharmaceutical Co.,Ltd
11.9.1 Beijing Biote Pharmaceutical Co.,Ltd Company Details
11.9.2 Beijing Biote Pharmaceutical Co.,Ltd Business Overview
11.9.3 Beijing Biote Pharmaceutical Co.,Ltd Microsphere Drug Introduction
11.9.4 Beijing Biote Pharmaceutical Co.,Ltd Revenue in Microsphere Drug Business (2020-2025)
11.9.5 Beijing Biote Pharmaceutical Co.,Ltd Recent Development
11.10 Livzon Pharmaceutical Group
11.10.1 Livzon Pharmaceutical Group Company Details
11.10.2 Livzon Pharmaceutical Group Business Overview
11.10.3 Livzon Pharmaceutical Group Microsphere Drug Introduction
11.10.4 Livzon Pharmaceutical Group Revenue in Microsphere Drug Business (2020-2025)
11.10.5 Livzon Pharmaceutical Group Recent Development
11.11 Luye Pharma
11.11.1 Luye Pharma Company Details
11.11.2 Luye Pharma Business Overview
11.11.3 Luye Pharma Microsphere Drug Introduction
11.11.4 Luye Pharma Revenue in Microsphere Drug Business (2020-2025)
11.11.5 Luye Pharma Recent Development
11.12 Grand Pharmaceutical Group Limited
11.12.1 Grand Pharmaceutical Group Limited Company Details
11.12.2 Grand Pharmaceutical Group Limited Business Overview
11.12.3 Grand Pharmaceutical Group Limited Microsphere Drug Introduction
11.12.4 Grand Pharmaceutical Group Limited Revenue in Microsphere Drug Business (2020-2025)
11.12.5 Grand Pharmaceutical Group Limited Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Johnson & Johnson
Takeda
Novartis
Ipsen Biopharmaceuticals, Inc
Ferring Pharmaceuticals
AstraZeneca
Pfizer
AbbVie
Beijing Biote Pharmaceutical Co.,Ltd
Livzon Pharmaceutical Group
Luye Pharma
Grand Pharmaceutical Group Limited

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂